Similar Papers

Paper Title
Journal
Date
Author
FRI0143 Risk Factors for Malignancy in Japanese Patients with Rheumatoid Arthritis Based on The IORRA Cohort during A 14-Year Observation Period
N Sugimoto ... K Shidara
Annals of the Rheumatic Diseases | VOL. 75
N Sugimoto, et. al.N Sugimoto ... K Shidara
01 Jun 2016
AB0387 Incidence and Risk Factors for Tuberculosis in Japanese Patients with Rheumatoid Arthritis During a 12-Year Observational Period Using the Iorra Cohort
R Yamaguchi ... E.I Inoue
Annals of the Rheumatic Diseases | VOL. 74
R Yamaguchi, et. al.R Yamaguchi ... E.I Inoue
01 Jun 2015
THU0165 Risk of herpes zoster in patients with rheumatoid arthritis in the biologics era based on the iorra cohort
R Yamaguchi ... Y Shimizu
Annals of the Rheumatic Diseases | VOL. 76
R Yamaguchi, et. al.R Yamaguchi ... Y Shimizu
01 Jun 2017
MON-330 Cancer Incidence in 1,296 Patients with Acromegaly Is Not Increased: A Nationwide Population-Based Study
Daniel S Olsson ... Oskar Ragnarsson
Journal of the Endocrine Society | VOL. 4
Daniel S Olsson, et. al.Daniel S Olsson ... Oskar Ragnarsson
08 May 2020
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
Dysfunctional KLRB1+CD8+ T-cell responses are generated in chronically inflamed systemic sclerosis skin.
Alyxzandria M Gaydosik ... Patrizia Fuschiotti
Annals of the rheumatic diseases | VOL. -
Alyxzandria M Gaydosik, et. al.Alyxzandria M Gaydosik ... Patrizia Fuschiotti
01 Feb 2025
Lipidomics unravels lipid changes in osteoarthritis articular cartilage.
Qiongfei Zhou ... Rik J Lories
Annals of the rheumatic diseases | VOL. -
Qiongfei Zhou, et. al.Qiongfei Zhou ... Rik J Lories
01 Feb 2025
Post hoc comparison of the effectiveness of tocilizumab, rituximab, mycophenolate mofetil, and cyclophosphamide in patients with SSc-ILD from the EUSTAR database.
Qingran Yan ... Oliver Distler
Annals of the rheumatic diseases | VOL. -
Qingran Yan, et. al.Qingran Yan ... Oliver Distler
01 Feb 2025
Reduced organ damage accumulation in adult patients with SLE on anifrolumab plus standard of care compared to real-world external controls.
Zahi Touma ... Miina Waratani
Annals of the rheumatic diseases | VOL. -
Zahi Touma, et. al.Zahi Touma ... Miina Waratani
01 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.